Cargando…

Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa

Ganoderma lucidum is a well-known medicinal mushroom that has been used for the prevention and treatment of different ailments to enhance longevity and health specifically in China, Japan, and Korea. It was known as “God’s herb” in ancient China as it was believed to prolong life, enhance the youthf...

Descripción completa

Detalles Bibliográficos
Autores principales: Oke, M. A., Afolabi, F. J., Oyeleke, O. O., Kilani, T. A., Adeosun, A. R., Olanbiwoninu, A. A., Adebayo, E. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441938/
https://www.ncbi.nlm.nih.gov/pubmed/36071846
http://dx.doi.org/10.3389/fphar.2022.952027
_version_ 1784782700746375168
author Oke, M. A.
Afolabi, F. J.
Oyeleke, O. O.
Kilani, T. A.
Adeosun, A. R.
Olanbiwoninu, A. A.
Adebayo, E. A.
author_facet Oke, M. A.
Afolabi, F. J.
Oyeleke, O. O.
Kilani, T. A.
Adeosun, A. R.
Olanbiwoninu, A. A.
Adebayo, E. A.
author_sort Oke, M. A.
collection PubMed
description Ganoderma lucidum is a well-known medicinal mushroom that has been used for the prevention and treatment of different ailments to enhance longevity and health specifically in China, Japan, and Korea. It was known as “God’s herb” in ancient China as it was believed to prolong life, enhance the youthful spirit and sustain/preserve vitality. G. lucidum is seldom collected from nature and is substantially cultivated on wood logs and sawdust in plastic bags or bottles to meet the international market demand. Both in vitro and in vivo studies on the copious metabolic activities of G. lucidum have been carried out. Varied groups of chemical compounds including triterpenoids, polysaccharides, proteins, amino acids, nucleosides, alkaloids, steroids, lactones, lectins, fatty acids, and enzymes with potent pharmacological activities have been isolated from the mycelia and fruiting bodies of G. lucidum. Several researchers have reported the abundance and diversification of its biological actions triggered by these chemical compounds. Triterpenoids and polysaccharides of G. lucidum have been reported to possess cytotoxic, hepatoprotective, antihypertensive, hypocholesterolemic, antihistaminic effects, antioxidant, antimicrobial, anti-inflammatory, hypoglycemic antiallergic, neuroprotective, antitumor, immunomodulatory and antiangiogenic activities. Various formulations have been developed, patented, and utilized as nutraceuticals, cosmeceuticals, and pharmaceuticals from G. lucidum extracts and active compounds. Thus, this review presents current updates on emerging infectious diseases and highlights the scope, dynamics, and advances in infectious disease management with a particular focus on Ganoderma lucidum, an unutilized natural medicine as a promising future solution to emerging diseases in Africa. However, details such as the chemical compound and mode of action of each bioactive against different emerging diseases were not discussed in this study.
format Online
Article
Text
id pubmed-9441938
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94419382022-09-06 Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa Oke, M. A. Afolabi, F. J. Oyeleke, O. O. Kilani, T. A. Adeosun, A. R. Olanbiwoninu, A. A. Adebayo, E. A. Front Pharmacol Pharmacology Ganoderma lucidum is a well-known medicinal mushroom that has been used for the prevention and treatment of different ailments to enhance longevity and health specifically in China, Japan, and Korea. It was known as “God’s herb” in ancient China as it was believed to prolong life, enhance the youthful spirit and sustain/preserve vitality. G. lucidum is seldom collected from nature and is substantially cultivated on wood logs and sawdust in plastic bags or bottles to meet the international market demand. Both in vitro and in vivo studies on the copious metabolic activities of G. lucidum have been carried out. Varied groups of chemical compounds including triterpenoids, polysaccharides, proteins, amino acids, nucleosides, alkaloids, steroids, lactones, lectins, fatty acids, and enzymes with potent pharmacological activities have been isolated from the mycelia and fruiting bodies of G. lucidum. Several researchers have reported the abundance and diversification of its biological actions triggered by these chemical compounds. Triterpenoids and polysaccharides of G. lucidum have been reported to possess cytotoxic, hepatoprotective, antihypertensive, hypocholesterolemic, antihistaminic effects, antioxidant, antimicrobial, anti-inflammatory, hypoglycemic antiallergic, neuroprotective, antitumor, immunomodulatory and antiangiogenic activities. Various formulations have been developed, patented, and utilized as nutraceuticals, cosmeceuticals, and pharmaceuticals from G. lucidum extracts and active compounds. Thus, this review presents current updates on emerging infectious diseases and highlights the scope, dynamics, and advances in infectious disease management with a particular focus on Ganoderma lucidum, an unutilized natural medicine as a promising future solution to emerging diseases in Africa. However, details such as the chemical compound and mode of action of each bioactive against different emerging diseases were not discussed in this study. Frontiers Media S.A. 2022-08-22 /pmc/articles/PMC9441938/ /pubmed/36071846 http://dx.doi.org/10.3389/fphar.2022.952027 Text en Copyright © 2022 Oke, Afolabi, Oyeleke, Kilani, Adeosun, Olanbiwoninu and Adebayo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Oke, M. A.
Afolabi, F. J.
Oyeleke, O. O.
Kilani, T. A.
Adeosun, A. R.
Olanbiwoninu, A. A.
Adebayo, E. A.
Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa
title Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa
title_full Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa
title_fullStr Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa
title_full_unstemmed Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa
title_short Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa
title_sort ganoderma lucidum: unutilized natural medicine and promising future solution to emerging diseases in africa
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441938/
https://www.ncbi.nlm.nih.gov/pubmed/36071846
http://dx.doi.org/10.3389/fphar.2022.952027
work_keys_str_mv AT okema ganodermalucidumunutilizednaturalmedicineandpromisingfuturesolutiontoemergingdiseasesinafrica
AT afolabifj ganodermalucidumunutilizednaturalmedicineandpromisingfuturesolutiontoemergingdiseasesinafrica
AT oyelekeoo ganodermalucidumunutilizednaturalmedicineandpromisingfuturesolutiontoemergingdiseasesinafrica
AT kilanita ganodermalucidumunutilizednaturalmedicineandpromisingfuturesolutiontoemergingdiseasesinafrica
AT adeosunar ganodermalucidumunutilizednaturalmedicineandpromisingfuturesolutiontoemergingdiseasesinafrica
AT olanbiwoninuaa ganodermalucidumunutilizednaturalmedicineandpromisingfuturesolutiontoemergingdiseasesinafrica
AT adebayoea ganodermalucidumunutilizednaturalmedicineandpromisingfuturesolutiontoemergingdiseasesinafrica